Tag: Grahame M. Morris

The below Parliamentary question was asked by Grahame M. Morris on 2015-01-14.

To ask the Secretary of State for Health, what discussions he has had about extending the remit of the Cancer Drugs Fund to include access to other cancer treatments such as advanced stereotactic radiotherapy.

George Freeman

We announced a £160 million boost to the Cancer Drugs Fund at the end of August 2014.

NHS England announced on 12 January 2015 that it plans to increase the level of investment for drugs in the Cancer Drugs Fund from £280 million in 2014-15 to an expected £340 million in 2015-16.

NHS England has also announced the extension of its Commissioning through the Evaluation programme to include stereotactic ablative radiotherapy (SABR). This will enable the number of cancer patients eligible to access SABR treatment to rise significantly, by 750 new patients a year and widen the number of cancers being treated.

The below Parliamentary question was asked by Grahame M. Morris on 2015-01-14.

To ask the Secretary of State for Health, what discussions he has had on improving access to advanced stereotactic radiotherapy for patients in the North East of England.

Jane Ellison

My Rt. hon. Friend the Secretary of State meets NHS England regularly to discuss a wide range of issues, including access to cancer treatment.

The below Parliamentary question was asked by Grahame M. Morris on 2015-01-14.

To ask the Secretary of State for Business, Innovation and Skills, what discussions he has had on how the Government will consult the public about the Transatlantic Trade and Investment Partnership.

Matthew Hancock

The Government regularly discusses the Transatlantic Trade and Investment Partnership with representatives from business, trade union, consumer and civil society groups. We will continue to seek to engage with all interested parties and provide information about the progress of discussions.

The below Parliamentary question was asked by Grahame M. Morris on 2015-01-14.

To ask the Secretary of State for Business, Innovation and Skills, what assessment he has made of the potential economic costs and benefits of the Transatlantic Trade and Investment Partnership for the North East of England.

Matthew Hancock

The Transatlantic Trade and Investment Partnership could deliver a substantial economic boost for people living in the North East. For example the chemicals sector, which has a large presence in the region, could particularly benefit. Based on independent economic analysis, the Government estimates that the North East’s share of increased exports could be up to £1.05 billion.

The below Parliamentary question was asked by Grahame M. Morris on 2015-01-14.

To ask the Secretary of State for Business, Innovation and Skills, which organisations he has consulted on the negotiations on the Transatlantic Trade and Investment Partnership.

Matthew Hancock

The Government is committed to full and effective consultation on the Transatlantic Trade and Investment Partnership and has discussed it with a broad range of stakeholders across the UK. Organisations consulted include business representative bodies, such as the CBI and the Federation of Small Business, and trades unions including the TUC, Unison, the GMB and others. We have also regularly consulted Which? to discuss the potential benefits to consumers and of a coalition of civil society campaigners, including the Trade Justice Movement, Friends of the Earth, War on Want and the World Development Movement.

The below Parliamentary question was asked by Grahame M. Morris on 2015-01-13.

To ask Mr Chancellor of the Exchequer, what criteria his Department uses to assess the effectiveness of quantitative easing.

Andrea Leadsom

The UK’s monetary policy framework, set out in the Bank of England Act 1998, gives operational responsibility for monetary policy to the independent Monetary Policy Committee (MPC).

The below Parliamentary question was asked by Grahame M. Morris on 2015-02-11.

To ask the Secretary of State for Transport, pursuant to the Answer of 9 February 2015 to Question 223358, how many UK-based (a) ratings and (b) officers will be employed on the re-named Allseas vessel contracted by Shell to carry out major decommissioning work in the Brent Field.

Mr John Hayes

The nationality/country of residence of the crew members for an individual vessel is entirely a commercial decision and this information is not provided to government.

The below Parliamentary question was asked by Grahame M. Morris on 2015-02-11.

To ask the Secretary of State for Energy and Climate Change, pursuant to the Answer of 9 February 2015 to Question 223360, what proportion of the 1,000 skilled people he expects to be UK-based; and whether he expects these people to be subject to a collective bargaining agreement.

Matthew Hancock

The information requested is not available.

The below Parliamentary question was asked by Grahame M. Morris on 2014-06-11.

To ask the Secretary of State for Business, Innovation and Skills, what discussions his Department has had with B&K Universal Ltd, Yorkshire Evergreen or their associates relating to their planning application for a facility at Grimston, Yorkshire for the breeding of dogs and other animals for laboratory use in the last 12 months.

Mr David Willetts

UK Trade and Investment and BIS officials provided general planning advice to B&K Universal in the last year at the company’s request. BIS officials met with B&K’s parent company Marshall and signposted other sources of advice and information. Officials were also asked to provide advice on EU Directive 2010/63 and referred this query to the Home Office as the Department with responsibility for implementing the Directive in the UK.

The use of animals in scientific research remains a vital tool in improving our understanding of how biological systems work both in health and disease and in the development of new medicines and treatments vital for human health and for that of animals. It also underpins the success of the UK’s life science sector which has one of the strongest and most productive industries in the world.

The UK has a rigorous regulatory system which ensures that animal research and testing is carried out only where no practicable alternative exists, and under controls which keep suffering to the minimum.

The Government is committed to working to further reduce the use of animals in scientific research and in February 2013 published its delivery plan. This demonstrates our commitment to the “3Rs”: where possible to replace animal use, reduce the number of animals used and to refine the procedures involved so as to find additional ways to minimise suffering. https://www.gov.uk/government/publications/working-to-reduce-the-use-of-animals-in-research-delivery-plan

“

The below Parliamentary question was asked by Grahame M. Morris on 2014-06-11.

To ask the Secretary of State for the Home Department, what discussions her Department has had with B&K Universal Ltd, Yorkshire Evergreen or their associates about their planning application for a facility at Grimston, Yorkshire for the breeding of dogs and other animals for laboratory use in the last 12 months.

Norman Baker

Home Office officials have advised B&K Universal Ltd of the requirements for the proposed facility of European Directive 2010/63/EU, which was implemented in the UK and other Member States on 1 January 2013.

Decisions on planning applications are a matter for the relevant local planning authority.